Large peer-support community focused on tapering antidepressants and other psychiatric drugs, documenting withdrawal symptoms, windows and waves, stabilization, and recovery experiences.
References
Organized references for psychiatric medication withdrawal, tapering, symptom education, clinical guidance, and support resources.
These references include a range of perspectives, including clinical guidance, peer-support communities, advocacy organizations, educational articles, and published literature. Inclusion does not imply endorsement of all viewpoints or medical recommendations.
Antidepressants
References focused on antidepressant withdrawal, tapering, symptom patterns, adverse reactions, hyperbolic tapering, and patient education.
Education & Peer Support
Community explanation of the windows and waves pattern, describing how withdrawal symptoms may fluctuate rather than improve in a straight line.
Community guide explaining gradual dose reductions, the 10% tapering approach, and the basic idea behind hyperbolic tapering.
Practical discussion of calculating smaller doses, liquid dilutions, spreadsheets, and tapering calculators.
Peer-support discussion focused on emotional spirals, distress, and coping during withdrawal or destabilization.
Community discussion of protracted withdrawal and post-acute withdrawal symptoms after stopping or reducing psychiatric medications.
Discussion of immediate or early adverse reactions that may occur shortly after starting an antidepressant or after only a few doses.
Medication-Specific Tapering Guides
Medication-specific tapering information for trazodone.
Medication-specific tapering information for vortioxetine.
Medication-specific tapering information for mirtazapine.
Medication-specific tapering information for duloxetine.
Medication-specific tapering information for citalopram.
Medication-specific tapering information for fluoxetine.
Medication-specific tapering information for paroxetine.
Medication-specific tapering information for desvenlafaxine.
Medication-specific tapering information for escitalopram.
Medication-specific tapering information for sertraline.
Guides, Organizations & Symptom Education
Overview of antidepressants, adverse effects, and medication-related concerns from RxISK.
Educational overview of antidepressant side effects and adverse drug reactions.
Guide discussing antidepressant discontinuation, withdrawal symptoms, and practical considerations when stopping.
Patient-facing guidance from the Royal College of Psychiatrists on withdrawal symptoms, tapering, and stopping antidepressants more gradually.
Educational resource about intrusive thoughts, which some people may experience or notice more intensely during anxiety states, withdrawal, or nervous system destabilization.
Printables
Printable version of the Royal College of Psychiatrists guide on stopping antidepressants.
Studies & Articles
Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry. 2019;6(6):538–546. doi: 10.1016/S2215-0366(19)30032-X.
van Os J, Groot PC. Outcomes of hyperbolic tapering of antidepressants. Therapeutic Advances in Psychopharmacology. 2023;13:20451253231171518. Study discussing outcomes associated with hyperbolic tapering strips.
Framer A. What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications. Therapeutic Advances in Psychopharmacology. 2021;11:2045125321991274. doi: 10.1177/2045125321991274.
Benzodiazepines
References focused on benzodiazepine education, withdrawal, protracted symptoms, tapering strategies, safer cessation, clinical guidance, and support resources.
Education & Resource Hubs
Overview from Inner Compass Initiative on benzodiazepines, their uses, risks, and withdrawal-related concerns.
Comprehensive benzodiazepine resource directory covering safer cessation, tapering, support, research, clinician education, and patient resources.
Educational overview explaining benzodiazepines, common uses, risks, dependence, and withdrawal concerns.
Information about acute withdrawal, post-withdrawal symptoms, and commonly reported benzodiazepine withdrawal experiences.
Educational page describing benzodiazepine withdrawal syndrome, symptoms, and related risks.
Information about prolonged or protracted symptoms that may persist after benzodiazepine reduction or discontinuation.
Overview of benzodiazepine tapering strategies, tapering challenges, and safer reduction considerations.
Information about medications and supplements that may be of concern for some people during benzodiazepine use, cessation, or withdrawal.
Studies, Clinical Guidance & Patient Guides
Benzodiazepine deprescribing guidance from the Colorado Consortium for Prescription Drug Abuse Prevention, focused on gradual tapering, dependence, withdrawal reactions, and clinical considerations.
Professor C. Heather Ashton’s manual on benzodiazepines, how they work, dependence, withdrawal, and tapering approaches. Frequently cited in benzodiazepine withdrawal communities.
Brunner E, Chen C-YA, Klein T, et al. Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Benzodiazepine Risks Outweigh Benefits. Journal of General Internal Medicine. 2025;40(12):2814–2859. doi: 10.1007/s11606-025-09499-2.
Patient-facing benzodiazepine tapering guide associated with the ASAM-led benzodiazepine tapering guideline.
Huff C. 10 Tips to Help Patients Through Benzodiazepine Withdrawal. Benzodiazepine Information Coalition. Practical clinician-facing tips for supporting physiologically dependent patients through benzodiazepine withdrawal.